About Matt Rightmire

This author has not yet filled in any details.
So far Matt Rightmire has created 62 blog entries.

Avitide, Inc., Raises Series E Financing from Sands Capital Ventures

Avitide, Inc., the industry leader in the discovery, and manufacture of exclusive biopharmaceutical affinity purification solutions, today announced the closing of a Series E financing. Sands Capital Ventures, LLC led the financing round with participation from Mithril Capital Management, Polaris Partners, NeoMed Management, OrbiMed Advisors, and Borealis Ventures. Ian Ratcliffe (Sands Capital Ventures) joined Avitide’s [...]

By | June 21st, 2017|Dartmouth Innovation, New Hampshire, News|

WeWork has acquired venture-backed Fieldlens

WeWork, the seven-year-old, New York-based co-working juggernaut that more recently entered into the business of co-living, has been making a series of small acquisitions with some of the $1.8 billion that it has officially gathered from investors. Its latest acquisition: Fieldlens, a 5.5-year-old mobile communication system for the construction industry that aims to replace calls, [...]

By | June 7th, 2017|Design & Engineering Software, News|

EagleView Accelerates Machine Learning Development with Acquisition of OmniEarth

EagleView®, the leading provider of aerial imagery and data analytics for government and commercial industries, is proud to announce the acquisition of OmniEarth, developer of machine learning technologies and decision-making tools for the water resource management, energy and insurance markets. With this acquisition, EagleView gains OmniEarth’s machine learning capabilities, resulting in higher accuracy and precision [...]

By | April 26th, 2017|Design & Engineering Software, News|

Oracle Buys Dyn

Extends the World’s Most Comprehensive Cloud Computing Platform with the Leading Cloud-based Internet Performance and Domain Name System (DNS) Solution Oracle today announced that it has signed an agreement to acquire Dyn, the leading cloud-based Internet Performance and DNS provider that monitors, controls, and optimizes Internet applications and cloud services to deliver faster access, reduced [...]

By | November 21st, 2016|New Hampshire, News|

Avitide, Inc., Secures Series D Financing from Mithril to Expand Affinity Resin Discovery Platform and Resin Manufacturing Operations

Avitide, Inc., the leader in the discovery, manufacture, and supply of novel affinity purification solutions for the biopharmaceutical industry, closed its Series D financing. Mithril Capital Management, LLC led the financing round. Avitide rapidly and reliably develops high-performance affinity purification solutions for the manufacture of life-saving therapeutics, including enzymes, novel scaffolds, multi-specific antibodies, gene therapies, [...]

By | September 12th, 2016|Dartmouth Innovation, New Hampshire, News|

Adimab Announces Antibody Discovery Collaboration with Takeda

Adimab LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced a multi-target partnership with Takeda Pharmaceutical Company Ltd. Under the terms of the agreement, Adimab will use its proprietary platform to discover and optimize antibodies against multiple targets chosen by Takeda, who will have the right [...]

By | April 26th, 2016|Dartmouth Innovation, New Hampshire|

Avedro Receives FDA Approval for Photrexa Viscous, Photrexa and the KXL System for Corneal Cross-Linking

Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has received approval from the U.S. Food and Drug Administration (FDA) for Photrexa Viscous, Photrexa and the KXL System. Photrexa Viscous and Photrexa are photoenhancers indicated for use with the KXL System in corneal collagen cross-linking for the treatment of progressive keratoconus. Avedro’s Photrexa Viscous, Photrexa [...]

By | April 18th, 2016|Dartmouth Innovation, New Hampshire, News|

Mutant Yeast Are Cranking Out Pharma’s Next Superdrug

The offices of Adimab, a biotech company in Lebanon, New Hampshire, smell pleasantly of fresh bread. It’s an olfactory illusion, albeit a welcome one. Nobody is baking anything. The laboratory is lined with beaker after beaker of incubating Saccharomyces cerevisiae—yeast. So, no crusty treats, but instead Adimab is using all that yeast to cure cancer. [...]

By | March 10th, 2016|Dartmouth Innovation, New Hampshire, News|

Adimab Scientists Report the Isolation of Highly Potent Anti-Ebola Virus Antibodies from Recent Zaire Outbreak

Adimab, LLC, a global leader in the discovery of human antibodies, today reported the isolation of a broad panel of neutralizing anti-Ebola virus antibodies from a survivor of the recent Zaire outbreak. The work, published online today in the journal Science, highlights the remarkable speed of Adimab's recently launched single B cell isolation platform, and [...]

By | February 18th, 2016|New Hampshire|

Adimab Announces Technology Transfer Agreement with Merck – Fourth Company to Internalize the Platform

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that it has entered into a definitive agreement with Merck, known as MSD outside the United States and Canada, to transfer Adimab’s antibody technology to Merck Research Laboratories for the discovery and optimization of monoclonal and [...]

By | January 12th, 2016|Dartmouth Innovation, News|